California’s Division of Workers’ Compensation has posted the second interim status report on its efforts to promulgate regulations for an evidence-based workers’ compensation drug formulary.
The regulations were as required by a law passed last year, Assembly Bill 1124.
The report can found on the DWC website.
The goal is to adopt the drug formulary by July 1 that will be consistent with California’s Medical Treatment Utilization Schedule for medications prescribed in the workers’ comp system.
DWC will accept oral testimony and written comments on the proposed formulary regulations at a public hearing on today from 10 a.m. to 5 p.m. at the Elihu Harris State Office Building Auditorium in Oakland.
DWC will review all comments received to determine if changes to the regulatory proposal are warranted. If so, DWC will issue a revised proposal for a 15-day public comment period. Upon completion of the rulemaking action, the regulations will be submitted to the Office of Administrative Law for approval and filing with the Secretary of State.
Was this article valuable?
Here are more articles you may enjoy.
Why New York’s Attorney General Objects to Trump’s Bond Insurer 
4,800 Claims Handled by Unlicensed Adjusters in Florida After Irma, Lawsuit Says 
GM Ends OnStar Driver Safety Program After Privacy Complaints 
Chubb to Acquire MGA Healthy Paws From Aon 
